LAT8881
Lumbar Radicular Pain (Sciatica)
Phase 1bCompleted; safety in >700 patients
Key Facts
Indication
Lumbar Radicular Pain (Sciatica)
Phase
Phase 1b
Status
Completed; safety in >700 patients
Company
About Lateral Pharma
An Australian biotech developing first-in-class LanCL-targeting therapies for neuropathic pain, neurodegeneration, and healthy ageing.
View full company profileTherapeutic Areas
Other Lumbar Radicular Pain (Sciatica) Drugs
| Drug | Company | Phase |
|---|---|---|
| SX600 | Frenelle Pharma | Phase 2 |